Verge Genomics Company

Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Technology: Bioinformatics, Biotechnology, Genetics, Health Care, Machine Learning, Neuroscience, Therapeutics
Industry: Early Drug Development
Headquarters: San Francisco, California, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 25
Total Funding: 134120000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-12-16
Last Funding Type: Series B

Visit Website
hello@vergegenomics.com
https://twitter.com/VergeGenomics
Register and Claim Ownership